Bristol-Myers sued for $6.4 billion in alleged delay in seeking FDA approval for Celgene drug

For this year Bristol-Myers Squibb 's revenue will be around 46.1 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2020's revenue of 42.52 billion USD.

Historical revenues and results Bristol-Myers Squibb plus estimates 2020

The analysts expect for 2021 a net profit of 16.74 billion USD. For this year the consensus of Bristol-Myers Squibb 's result per share is a profit of 7.44 USD. The price/earnings-ratio is then 9.06.

Per share the analysts expect a dividend of 1.95 USD per share. Thus the dividend yield equals 2.89 percent. The average dividend yield of the pharmaceutical companies is a moderate 1.39 percent.

Bristol-Myers Squibb 's market value equals around 150.14 billion . The Bristol-Myers Squibb stock was the past 12 months quite unstable. Since last June the stock is even 23 percent higher. This year the stock price moved between 54 and 68 dollar.

Historical stock prices Bristol-Myers Squibb from 2007 till 2021

On Friday the stock closed at 67.39 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.